Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Prognostic role of Toll-like receptors in cancer: a meta-analysis

Authors Wang Q, Zhang X, Xiao T, Pan C, Liu X, Zhao Y

Received 17 April 2018

Accepted for publication 8 June 2018

Published 30 July 2018 Volume 2018:14 Pages 1323—1330


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Deyun Wang

Qingwen Wang,1 Xiankai Zhang,1 Tingting Xiao,2 Chenhua Pan,1 Xing Liu,3,4 Yulan Zhao1

1Department of Physiology, School of Life Sciences, East China Normal University, Shanghai, People’s Republic of China; 2Department of Botany, School of Life Sciences, Shanghai Normal University, Shanghai, People’s Republic of China; 3Department of Central Laboratory Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 4Shanghai Biochip Corporation Ltd./National Engineering Center for Biochip at Shanghai, Shanghai, People’s Republic of China

Background: Recent studies have shown that Toll-like receptors (TLRs) may be associated with cancers. The aim of this meta-analysis is to summarize the predicting role of TLRs for survival in patients with a variety of carcinomas.
Materials and methods: Eligible studies were identified and assessed for quality through multiple search strategies. We collected data from studies investigating the relationship between the expression level of TLRs and survival in cancer patients. Studies were pooled and combined hazard ratios (HRs) of TLRs for survival were analyzed.
Results: A total of 24 studies, including 2,812 patients with various cancers, were identified for the meta-analysis. Importantly, this meta-analysis showed that higher expression levels of TLR4 or TLR7 in tumor tissues could predict poorer survival, with the pooled HR being 1.29 (95% CI: 1.17, 1.42) and 1.71 (95% CI: 1.38, 2.12), respectively. However, higher expression of TLR9 had no significant association with outcome as HR was 0.84 (95% CI: 0.62, 1.115). Heterogeneity existed in TLR4 and TLR9 studies (P-value <0.001) but not in TLR7 studies (P-value >0.05).
Conclusion: The expression level of TLR4 or TLR7 in cancerous tissue may have a prognosis value in patients with various cancers.

Keywords: Toll-like receptors, cancers, prognosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]